Research June 10, 2021 CureVac vaccine protocol: public-private collaboration success story Clinical trials for the CureVac vaccine carried out by private institutions such as TecSalud and the Mexican government have made public-private synergy necessary.
Entrepreneurs June 08, 2021 Mexican woman wins award for creating device against parasitic disease Social Skin rewards young people who have innovative social impact projects. This year, a Tec de Monterrey student is one of the winners.
Health May 12, 2021 Tec graduate researcher discovers new lung cell and wins US grant Lisandra Vila Ellis, who holds a medical degree from the Tec de Monterrey School of Medicine, has won a United States research project grant after discovering a new lung cell.
Health May 11, 2021 Tec students create global health convergence platform Medical students from the Tec want to create agents of social change through a digital community focused on public and global health.
Research April 12, 2021 Tec is world leader in using AI to detect diabetic retinopathy For enabling early detection in places where there are no expert ophthalmologists physically present, the Tec’s project was incorporated into the “Global Partnership on Artificial Intelligence” (GPAI).
Health February 25, 2021 Mexican female scientist wins award for research on curing blindness An initiative from 3M has recognized 25 Latin American women in science, including a professor from the School of Medicine and Health Sciences (EMCS) on Monterrey campus.
Research February 24, 2021 Nobel laureate calls for trust in scientific consensus on vaccines Aaron Ciechanover, an Israeli scientist who won the 2004 Nobel Prize in Chemistry, calls for increased media campaigns in favor of COVID-19 vaccination.
Research February 24, 2021 Genome sequencing: work of new laboratory from Tec and FEMSA The Tec BASE Genome Sequencing Laboratory has specialized equipment from American company Ilumina, one of the most prominent in the field.
Research February 24, 2021 MIT.nano director: “the future will be measured in nanometers” Dr. Vladimir Bulović, director and founder of MIT.nano, shared nanotechnology trends in a presentation at Tec de Monterrey’s 51st Research and Development Conference.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
